Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Asep Medical Featured in National Documentary
Asep was selected to be a part of a special series titled Empowered, Hosted by Meg Ryan, focusing on science, technology and medicine leaders. VANCOUVER, BC , Aug. 1, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that its innovative sepsis diagnostic test will be getting national exposure in the US through a documentary series called Empowered, Hosted by Meg Ryan, now being aired on Public Television.» Mehr auf prnewswire.com
Asep Joint Venture Company, SepSMART, obtains Business License and is Formally Registered in China
VANCOUVER, BC , April 5, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep" or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that its joint venture company with leading Chinese biotech company Sansure Biotech Inc. ("Sansure"), Hunan Sanway SepSMART Ltd. ("SepSMART"), which is based in Changsha, China, has obtained its business license and is now formally registered in China, which marks the final step for completion of the definitive joint venture agreement (the "JV Agreement") signed on October 27, 2023.» Mehr auf prnewswire.com
Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar this Friday, March 22, 2024, at 4 pm EST
CLICK HERE TO REGISTER VANCOUVER, BC , March 18, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that it is holding an online webinar on March 22, 2024, at 4:00 pm EST to provide significant updates on the company's latest milestones. Investors, potential investors, analysts, and members of the medical community are invited to register for the webinar to review Asep Inc.'s groundbreaking diagnostic and therapeutic technologies and learn first-hand about the status of the Company's plans to list on the Nasdaq Exchange.» Mehr auf prnewswire.com
Unternehmenszahlen
(EUR) | Juni 2024 | |
---|---|---|
Umsatz | 50,41k | - |
Bruttoeinkommen | 23,58k | 294,41% |
Nettoeinkommen | −764,58k | 55,46% |
EBITDA | −675,42k | 44,86% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 2,90 Mio€ |
Anzahl Aktien | 75,42 Mio |
52 Wochen-Hoch/Tief | 0,24€ - 0,0365€ |
Dividenden | Nein |
Beta | -2,26 |
KGV (PE Ratio) | −0,82 |
KGWV (PEG Ratio) | −0,03 |
KBV (PB Ratio) | 0,38 |
KUV (PS Ratio) | 24,94 |
Unternehmensprofil
Asep Medical Holdings Inc. konzentriert sich über seine Tochtergesellschaft ASEP Medical Inc. auf die Entwicklung eines Frühdiagnoseinstruments für Sepsis und peptidische therapeutische Behandlungen für verschiedene Anwendungen. Das Unternehmen war früher als Trenchant Life Sciences Investment Corp. bekannt und änderte seinen Namen in Asep Medical Holdings Inc. Asep Medical Holdings Inc. wurde im Jahr 2020 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.
Name | ASEP Medical Holdings |
CEO | Dr. Robert E. W. Hancock FRSC, OC, Ph.D. |
Sitz | Vancouver, bc Kanada |
Website | |
Industrie | Gesundheitswesen: Ausstattung und Produkte |
Börsengang | 22.11.2021 |
Mitarbeiter | 6 |
Ticker Symbole
Börse | Symbol |
---|---|
Cnq | ASEP.CN |
Frankfurt | JJ8.F |
Hamburg | JJ8.HM |
Düsseldorf | JJ8.DU |
München | JJ8.MU |
Pnk | SEPSF |
Assets entdecken
Shareholder von ASEP Medical Holdings investieren auch in folgende Assets